
Mario Javier Pineda MD PhD
Gynecologic Oncology
Assistant Professor
Join to view full profile
685 S Dobson RdChandler, AZ 85224
Phone+1 480-821-2838
Fax+1 480-821-9444
Dr. Pineda is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Obstetrics and Gynecology, 2007 - 2011
University of Washington School of MedicineClass of 2007
Certifications & Licensure
AZ State Medical License 2017 - 2027
CA State Medical License 2008 - 2020
IL State Medical License 2011 - 2017
American Board of Obstetrics and Gynecology Obstetrics & Gynecology
American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2015-2016
- CMS Meaningful Use Stage 1 Certification Northwestern popHealth for Eligible Providers, Northwestern University, 2015-2016
- CMS Meaningful Use Stage 1 Certification Northwestern Meaningful Use Data Warehouse Application for Eligible Providers, Northwestern University, 2015-2016
Publications & Presentations
PubMed
- 7 citationsClinical and Biological Activity of Chemoimmunotherapy in Advanced Endometrial Adenocarcinoma: A Phase II Trial of the Big Ten Cancer Research Consortium.Emma Longley Barber, Siqi Chen, Mario Javier Pineda, Sharon E Robertson, Emily K Hill
Cancer Research Communications. 2022-10-01 - 7 citationsEfficacy and safety of tivozanib in recurrent, platinum-resistant ovarian, fallopian tube or primary peritoneal cancer, an NCCN phase II trialMathew Cowan, Wendy M. Swetzig, Valery Adorno-Cruz, Mario Javier Pineda, Nikki L. Neubauer
Gynecologic Oncology. 2021-10-01 - 9 citationsCorrection to: “Safety and dose modification for patients receiving niraparib”Jonathan S. Berek, Ursula A. Matulonis, U. Peen, Prafull Ghatage, Sven Mahner
Annals of Oncology. 2019-05-01
Press Mentions
Diagnostic Conceptions and Management of Hyperkalemia in the Patient with ChronicFebruary 12th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: